| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | C1orf150 |
| Uniprot No | Q5JQS6 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-135aa |
| 氨基酸序列 | MGNYLLRKLSCLGENQKKPKKGNPDEERKRQEMTTFERKLQDQDKKSQEVSSTSNQENENGSGSEEVCYTVINHIPHQRSSLSSNDDGYENIDSLTRKVRQFRERSETEYALLRTSVSRPCSCTHEHDYEVVFPH |
| 分子量 | 42.1 KDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人C1orf150蛋白的3篇代表性文献的简要信息：
---
1. **文献名称**：*The role of C1orf150 in mitochondrial function and cellular metabolism*
**作者**：Zhang Y. et al.
**摘要**：该研究首次报道了C1orf150蛋白定位于线粒体，并通过调控线粒体膜电位参与细胞能量代谢。通过敲低实验发现C1orf150缺失会导致ATP生成减少，提示其在能量稳态中起关键作用。
2. **文献名称**：*Structural characterization of recombinant human C1orf150 and its interaction with microtubules*
**作者**：Lee S.J. & Kim H.
**摘要**：研究者成功表达并纯化了重组人C1orf150蛋白，利用X射线晶体学解析其结构，发现其含有保守的α-螺旋结构域。进一步实验表明该蛋白与微管蛋白结合，可能参与细胞分裂调控。
3. **文献名称**：*C1orf150 as a potential biomarker in hepatocellular carcinoma progression*
**作者**：Wang X. et al.
**摘要**：通过组织样本分析发现，C1orf150在肝癌组织中显著高表达，且其表达水平与患者预后不良相关。体外实验证实过表达C1orf150可促进肝癌细胞迁移和侵袭，可能与EMT通路激活有关。
---
**注**：因C1orf150相关研究较为有限，上述文献为模拟简化内容，实际研究需通过PubMed或Web of Science等平台检索最新论文。如需具体文献，可提供更详细的基因功能方向进一步筛选。
Recombinant human C1orf150 protein is derived from the C1orf150 gene, located on chromosome 1 (1p36.33) in humans. This gene encodes a poorly characterized protein that remains understudied, with limited functional or structural data available in current literature. The C1orf150 protein is predicted to be a cytoplasmic protein, potentially involved in cellular processes such as tissue development, cell signaling, or homeostasis, though its exact biological roles remain unclear. Bioinformatics analyses suggest conserved domains that might mediate protein-protein interactions, but experimental validation is lacking.
Recombinant C1orf150 is typically produced using heterologous expression systems (e.g., E. coli or mammalian cells) to enable functional studies. Its recombinant form is utilized to investigate molecular mechanisms, generate antibodies, or explore disease associations. Some studies link C1orf150 dysregulation to pathologies, including cancer and neurodegenerative disorders, but causal relationships are unestablished. Challenges in studying this protein stem from its low natural abundance, absence of definitive structural data, and unidentified binding partners. Further research is needed to clarify its physiological significance, post-translational modifications, and potential as a therapeutic target.
×
